PON2 C311S polymorphism has been associated with metabolic disorders of cholesterol transport, such as high plasma lipoprotein concentrations, coronary artery disease, complications in diabetes mellitus, ischemic stroke and Alzheimer’s dementia [57,58,59]. This evidence concerns the gene PON2 and Alzheimer disease.